Synthesis, molecular modelling studies of indolyl chalcone derivatives and their antimalarial activity evaluation

References

• Bhagat S, Sharma R, Sawant DM, Sharma L, Chakraborti AKJ. 2006. LiOH.H2O as a novel dual activation catalyst for highly efficient and easy synthesis of 1,3-diaryl-2-propenones by Claisen-Schmidt condensation under mild conditions. J Mol Catal A Chem. 244(1-2):20.
   Google Scholar
• Brinner KM, Powles MA, Schmatz DM, Ellman JA. 2005. Potent 4-aminopiperidine based antimalarial agents. Bioorg Med Chem Lett. 15(2):345–348.
   PubMed Web of Science ®Google Scholar
• Butcher GA, Sinden RE, Curtis C. 2000. Malaria: new ideas, old problems, new technologies. Parasitol Today. 16(2):43.
   PubMedGoogle Scholar
• Colletti SL, Myers RW, Darkin-Rattray SJ, Gurnett AM, Dulski PM, Galuska S, Allocco JJ, Ayer MB, Li C, Lim J, et al. 2001. Broad spectrum antiprotozoal agents that inhibit histone deacetylase: structure-activity relationships of apicidin. Part 2. Bioorg Med Chem Lett. 11(2):113–117.
   PubMed Web of Science ®Google Scholar
• Delarue S, Girault S, Maes L, Debreu-Fontaine MA, Labaeïd M, Grellier P, Sergheraert C. 2001. Synthesis and in vitro and in vivo antimalarial activity of new 4-anilinoquinolines. J Med Chem. 44(17):2827–2833.
   PubMed Web of Science ®Google Scholar
• Enserink M. 2000. Malaria researchers wait for industry to join fight. Science. 287(5460):1956.
   PubMed Web of Science ®Google Scholar
• Gardner MJ, Shallom SJ, Carlton JM, Salzberg SL, Nene V, Shoaibi A, Ciecko A, Lynn J, Rizzo M, Weaver B. 2000. Sequence of Plasmodium falciparum chromosomes 2, 10, 11 and 14. Nature. 419(6906):531–534.
   Web of Science ®Google Scholar
• Gaur R, Cheema HS, Kumar Y, Singh SP, Yadav DK, Darokar MP, Khan F, Bhakuni RS. 2015. In vitro antimalarial activity and molecular modeling studies of novel artemisinin derivatives. RSC Adv. 5(59):47959–47974.
   Web of Science ®Google Scholar
• Gaur R, Gupta VK, Pal A, Darokar MP, Bhakuni RS, Kumar B. 2015. Synthesis of novel chalcone derivatives as potential inhibitor of multidrug resistance efflux pumps in clinical isolates of methicillin resistant S. aureus: novel agents for combination therapy. RSC Adv. 5(8):5830–5845.
   Web of Science ®Google Scholar
• Gaur R, Thakur JP, Yadav DK, Kapkoti DK, Verma RK, Gupta N, Khan F, Saikia D, Bhakuni RS. 2015. Synthesis, antitubercular activity, and molecular modelling studies of analogues of isoliquiritigenin and liquiritigenin, bioactive components from Glycyrrhiza glabra. Med Chem Res. 24(9):3494–3503.
   Web of Science ®Google Scholar
• Gaur R, Yadav DK, Kumar S, Darokar MP, Khan F, Bhakuni RS. 2015. Molecular modelling based synthesis and in vitro evaluation of anticancer activity of indolyl chalcones. Curr Top Med Chem. 15(11):1003–1012.
   PubMed Web of Science ®Google Scholar
• Gaur R, Yadav KS, Verma RK, Yadav NP, Bhakuni RS. 2014. In vivo anti-diabetic activity of derivatives of isoliquiritigenin and liquiritigenin. Phytomedicine. 21(4):415–422.
   PubMed Web of Science ®Google Scholar
• Geneva: World Health Organization. 2015. Strategy for malaria elimination in the GMS (2015–2030). http://www.wpro.who.int/mvp/documents/strat_mal_elim_gms/en/.
   Google Scholar
• Jeong T-S, Soon Kim K, An S-J, Cho K-H, Lee S, Song Lee W. 2004. Novel 3,5-diarylpyrazolines as human acyl-CoA:cholesterolacyltransferase inhibitors. Bioorg Med Chem Lett. 14(11):2715.
   PubMed Web of Science ®Google Scholar
• Klayman DL. 1985. Qinghaosu (artemisinin): an antimalarial drug from China. Science. 228(4703):1049–1055.
   PubMed Web of Science ®Google Scholar
• Kumar A, Katiyar SB, Agarwal A, Chauhan PMS. 2003a. Perspective in antimalarial chemotherapy. Curr Med Chem. 10(13):1137.
   PubMed Web of Science ®Google Scholar
• Kumar A, Katiyar SB, Agarwal A, Chauhan PMS. 2003b. Current trends in antimalarial chemotherapy. Drugs Fut. 28(3):243.
   Web of Science ®Google Scholar
• Lecaille F, Kaleta J, Brömme D. 2002. Human and parasitic papain-like cysteine proteases: their role in physiology and pathology and recent developments in inhibitor design. Chem Rev. 102(12):4459–4488.
   PubMed Web of Science ®Google Scholar
• Lipinski CA, Lombardo F, Dominy B, Feeney P. 2001. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 46(1-3):3–26.
   PubMed Web of Science ®Google Scholar
• Luo XD, Shen CC. 1987. The chemistry, pharmacology, and clinical applications of qinghaosu (artemisinin) and its derivatives. Med Res Rev. 7(1):29–52.
   PubMed Web of Science ®Google Scholar
• Makler MT, Hinrichs D. 1993. Measurement of the lactate dehydrogenase activity of Plasmodium falciparum as an assessment of parasitemia. Am J Trop Med Hyg. 48(2):205–210.
   PubMed Web of Science ®Google Scholar
• Naß J, Efferth T. 2019. Development of artemisinin resistance in malaria therapy. Pharmacol Res. 146:104275.
   PubMed Web of Science ®Google Scholar
• Pandey KC, Wang SX, Sijwali PS, Lau AL, McKerrow JH, Rosenthal PJ. 2005. The Plasmodium falciparum cysteine protease falcipain-2 captures its substrate, hemoglobin, via a unique motif. Proc Natl Acad Sci USA. 102(26):9138–9143.
   PubMed Web of Science ®Google Scholar
• Rarey M, Kramer B, Lengauer T, Klebe G. 1996. A fast flexible docking method using an incremental construction algorithm. J Mol Biol. 261(3):470–489.
   PubMed Web of Science ®Google Scholar
• Rastelli G, Sirawaraporn W, Sompornpisut P, Vilaivan T, Kamchonwongpaisan S, Quarrell R, Lowe G, Thebtaranonth Y, Yuthavong Y. 2000. Interaction of pyrimethamine, cycloguanil, WR99210 and their analogues with Plasmodium falciparum dihydrofolate reductase: structural basis of antifolate resistance. Bioorg Med Chem. 8(5):1117–1128.
   PubMed Web of Science ®Google Scholar
• Ryckebusch A, Deprez-Poulain R, Debreu-Fontaine M-A, Vandaele R, Mouray E, Grellier P, Sergheraert C. 2003. Synthesis and antimalarial evaluation of new 1,4-bis(3-aminopropyl) piperazine derivatives. Bioorg Med Chem Lett. 13(21):3783–3787.
   PubMed Web of Science ®Google Scholar
• Shrivastava SK, Chauhan PMS. 2001. Present trends and future strategy in chemotherapy of malaria. Curr Med Chem. 8:1535.
   PubMed Web of Science ®Google Scholar
• Singh SB, Zink DL, Polishook JD, Dombrowski AW, Darkin-Rattray SJ, Schmatz DM, Goetz MA. 1996. Apicidins: novel cyclic tetrapeptides as coccidiostats and antimalarial agents from Fusarium pallidoroseum. Tetrahedron Lett. 37(45):8077–8080.
   Web of Science ®Google Scholar
• Srinivasan B, Johnson TE, Lad R, Xing C. 2009. Structure-activity relationship studies of chalcone leading to 3-hydroxy-4,3',4',5'-tetramethoxychalcone and its analogues as potent nuclear factor kappa B inhibitors and their anticancer activities. J Med Chem. 52(22):7228.
   PubMed Web of Science ®Google Scholar
• Ursos LMB, Roepe PD. 2002. Chloroquine resistance in the malarial parasite, Plasmodium falciparum. Med Res Rev. 22(5):465–491.
   PubMed Web of Science ®Google Scholar
• World Malaria Report. 2018.
   Google Scholar